Some U.S. drugmakers still see benefit of being in vaccine business

10/29/2004 | NYTimes.com

Despite recent shortages of flu vaccine, some pharmaceutical manufacturers believe making vaccines is still a good business. Several U.S. drugmakers are actively developing new vaccines for diseases ranging from infections obtained in kidney dialysis centers to viruses that cause ebola, West Nile and SARS to pneumococcal-caused diseases.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD